出 版 商:
TriMark Publications, LLC
排序:
Companion Biomarkers in Drug Development
2013/08/01
Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic. This link.. more USD 3,400
Microarray Markets
2013/08/01
Microarray technologies multiplex and miniaturize the analysis of tens of thousands of molecules for a variety of assays, including drug binding, mole.. more USD 3,400
Stem Cell Markets
2013/08/01
A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells u.. more USD 3,400
Point of Care Diagnostic Testing World Markets
2013/07/01
Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be ob.. more USD 3,400
Disposable Syringe Markets
2013/06/01
This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their.. more USD 3,400
Medical Imaging Markets
2013/06/01
The purpose of this TriMark Publications report is to describe the specific market segment of the diagnostics market sector called medical imaging. Me.. more USD 3,400
Veterinary Health Markets
2013/06/01
Veterinary health products, including veterinary pharmaceuticals, biologicals and medicated feed additives (MFAs), have transformed the health and wel.. more USD 3,400
Cancer Diagnostic Testing World Markets
2013/05/01
Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Inst.. more USD 3,400
Coagulation Diagnostic Testing Markets
2013/04/01
Coagulation testing, which encompasses both laboratory and point of care (POC) testing, will continue to be one of the most important segments of the .. more USD 3,400
Hemoglobin A1c Testing Markets
2013/03/01
Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes m.. more USD 3,400